How will HempFusion outperform its CBD competitors?

hempfusion CBD
Published on: February 18, 2021
Author: Editor

With the cannabis market having a renaissance in late 2020, HempFusion went public this January. What is exciting about the company’s products in the CBD 2.0 market? What is its growth strategy? How will it outperform its competitors? And how will the US government impact their business?

Check out this interview to learn about the investment opportunity with HempFusion (TSX:CBD.U).

About HempFusion Wellness Inc. (TSX:CBD.U)

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations.

NAI500’s new CEO Interview series is a program where we invite CEOs and senior executives of exciting public companies to uncover great investment opportunities for every day investors. If you don’t want to miss out on the great opportunities that we bring, subscribe to our YouTube channel and other social media channels below!

Disclaimer: NAI is being compensated for this content. Materials contained in this content are for information purposes only and is not intended to constitute an offering of securities in any jurisdiction. Nothing on this content should be construed as an offer, solicitation or recommendation to buy or sell products or securities.

Cannabis CEO Interview Consumer Products and Services Healthcare Hemp Life Science Marijuana